Strong word-of-mouth and critical acclaim from its surprise breakout opening have positioned A24’s three-hour Elizabeth Holmes documentary for robust theatrical legs through November 30. Released October 16 in 855 theaters, the Nathan Fielder–Lance Oppenheim film opened to $15.6 million—roughly double pre-release tracking—delivering the largest non-concert documentary debut in over a decade and the biggest per-screen average for a limited release since Borat. Near-universal reviews (97–99 Metacritic/RT) and 99% audience scores, plus over 2,000 sellouts and strong under-35 turnout, have driven consistent daily holds and midweek chart dominance, pushing the domestic cume past $25 million in its first week. Expansion to roughly 2,600 screens for the second weekend, with $20–25 million projections, supplies the next major catalyst. Traders see the combination of low budget, sustained cultural conversation around the Theranos saga, and proven audience appetite supporting totals clustering in the $125–175 million range by month’s end, though typical documentary drop-off patterns remain a modest risk factor.
该市场将根据《You Can See Everything》截至 2026年11月30日 的国内票房收入结算。待上映日(2026年10月16日)至 2026年11月30日 之间所有日期的数值均已最终确定(即不是制片方预估)后,将使用该影片在 The Numbers(https://www.the-numbers.com/)页面“Box Office”选项卡中“Daily Box Office Performance”下的数据结算本市场。 如果公布的数值恰好处于两个区间之间,本市场将按较高的区间结算。 请注意,本市场将根据 The Numbers 在“Box Office Performance”下提供的数据结算,统计截至 2026年11月30日(含当日)的数据,无论“国内”指的是仅美国,还是美国和加拿大等地区。 如果无法确定结算来源的数据是否为最终数据,本市场将保持开放,直到 https://www.boxofficemojo.com/ 和 https://www.the-numbers.com/ 均确认其最终数据。 如果截至 2026年12月31日 23:59 ET 仍没有最终数据,将选择另一个可信的结算来源。
机器翻译。如有争议,以原文为准。